To Ablate Or Not To Ablate: Current Management of Atrial Fibrillation

OSUWexnerbloglogo2014 CME Webcast Discusses To Ablate Or Not To Ablate Current Management of Atrial Fibrillation. In 1998, Dr. Michel Hice-uh-gaire, a cardiologist in Bordeaux, France, determined that the electrical triggers for atrial fibrillation were most commonly located in the pulmonary veins and that he could cure atrial fibrillation by ablating these triggers with a catheter. In the 2 decades since, ablation has a key element in the cardiologist’s toolbox to treat atrial fibrillation. But which patients are best served by medical treatment and which ones are best treated with catheter ablation? On this CME webcast, we’re going to explore this question. Joining our moderator is cardiac electrophysiologist and Professor of Internal Medicine at the Ohio State University, Dr. John Hummel.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Understand the risks of atrial fibrillation; and Understand when to initiate a strategy to maintain sinus rhythm.

You’ll also learn about the following:

  • Clinical implications of atrial fibrillation
  • Patient selection for atrial ablation
  • The ablation procedure
  • Return to work and exercise
  • Medication management after atrial ablation
  • Maze procedure
  • Management of recurrent atrial fibrillation after an ablation procedure
  • Apple Watch EKG app

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcasts Teaches on Cardiomyopathy

OSUWexnerbloglogo2014CME Webcasts Teaches on Cardiomyopathy. On this CME webcast, we are going to give you the information you need to be able to recognize cardiomyopathy in your patients and then to be able to identify the specific cause of their cardiomyopathy. Joining our moderator in the studio are two cardiologists from the Ohio State University. Dr. Sitaramesh Emani is an Assistant Professor of Internal Medicine and the Director of Heart Failure Clinical Trials at Ohio State. And Dr. Brent Lampert is an Assistant Professor of Internal Medicine and the Associate Program Director for the heart failure and transplant fellowship.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the common presenting signs and symptoms of cardiomyopathy; and REVIEW the diagnostic work up for cardiomyopathy.

You’ll also learn about the following:

  • Common causes of cardiomyopathy
  • Initial diagnostic steps in cardiomyopathy
  • Follow up imaging in patients with cardiomyopathy
  • Myocardial sarcoidosis
  • Physical examination of hypertrophic cardiomyopathy
  • Takotsubo cardiomyopathy
  • Diagnosing restrictive cardiomyopathies
  • Significance and work up of diastolic dysfunction
  • Chemotherapy-induced cardiomyopathy
  • Chagas Disease (Trypanosoma infection)

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.